SOURCE: ZELTIQ Aesthetics, Inc.

ZELTIQ Aesthetics, Inc.

November 13, 2014 05:30 ET

ZELTIQ® Aesthetics Named Fastest Growing Medical Device Company in North America by Deloitte's 2014 Technology Fast 500™

#1 Ranked ZELTIQ Attributes ~7,000 Percent Revenue Growth to Proprietary CoolSculpting® Technology

PLEASANTON, CA--(Marketwired - Nov 13, 2014) - ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ) today announced it is ranked number one in medical devices on Deloitte's Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. ZELTIQ grew 6,934 percent during this period.

Mark Foley, President and Chief Executive Officer of ZELTIQ, said, "Our first place ranking can be directly attributed to the clinical efficacy of our unique CoolSculpting technology in conjunction with our commercialization strategy. Our focus on outcomes through our industry leading sales force, enhanced training and education, and innovative marketing programs have resulted in our market leading revenue growth. We are excited about the incredible uptake and success of the company's performance and to have pioneered non-invasive body contouring, the fastest growing segment in aesthetics. In fact, nearly 1.5 million CoolSculpting treatments have been successfully performed worldwide. This year alone, 150,000 patients will experience the unique, FDA-cleared and patented technology behind our procedure that uses precise cooling to target fat cells, freezing them away for good. We will continue to invest in the initiatives that contributed to our top ranking and are encouraged by our ability to expand and grow the large, underpenetrated market for noninvasive fat reduction."

"The companies ranked on the 2014 Deloitte Technology Fast 500 continue to set the bar for their industry higher each year," said Eric Openshaw, vice chairman, Deloitte LLP and U.S. technology, media and telecommunications leader. "There are so many exciting products and smart thought leaders driving this list. We congratulate the Fast 500 companies and look forward to seeing them continue their momentum into 2015."

"For 20 years, the Deloitte Fast 500 rankings have honored the innovation that is part of these companies' DNA," added Jim Atwell, national managing partner of the emerging growth company practice, Deloitte & Touche LLP. "We're glad to be serving these high-growth companies, and helping the technology sector recognize the great strides and transformation these companies are making in their respective areas."

Overall, 2014 Technology Fast 500™ companies achieved revenue growth ranging from 135 percent to 123,678 percent from 2009 to 2013, with an average growth of 1,640 percent.

About Deloitte's 2014 Technology Fast 500™
Technology Fast 500, conducted by Deloitte LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies -- both public and private -- in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2009 to 2013.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, companies must be in business for a minimum of five years and be headquartered within North America.

About ZELTIQ® Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® system, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.